This receptor may have a similar role in COVID-19 patients who frequently present with abnormally high levels of IL-621,46–48, which drives the expression of the NKG2A ligand HLA-E on T cells, B cells, and macrophages49,50. The gene discussed is KLRC1; the disease is COVID-19.